Drugs / BGB-A3055
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05935098 | Aug 2023 → Jan 2026 | metastatic neoplasm, neoplasm | BeiGene | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BGB-A3055 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05935098 ↗ |
| Route | Intravenous | “Administered intravenously” NCT05935098 ↗ |